Home Top Movers Aethlon Medical Inc. (AEMD) stock falls during after-hour session. What has been...

Aethlon Medical Inc. (AEMD) stock falls during after-hour session. What has been happening lately?

Aethlon Medical Inc. (NASDAQ: AEMD) stock surged by 1.24% at the last close whereas the AEMD stock price declines by 6.13% in the after-hours trading session. There is no recent news available regarding the change happening in AEMD share price, as of yet. Aethlon Medical is a company that focuses on the development of products which could help in the diagnosis and treatment of organ-threatening diseases. It is basically a medical device technology company.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Past Development

Since there is no recent news available to understand the graph of Aethlon Medical’s stock price therefore we will look at the previous important event happened such as Aethlon Medical announced 3Q FY2021 results and issued a revised forecast on the two clinical trials currently ongoing on February 11, 2021. AEMD is building internal infrastructure to sustain its rising prospects, which include designing drugs to detect and cure diseases in oncology and infectious diseases that are life and organ-threatening and not treated by currently licensed therapies.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

The effect of therapeutic exosome loss using the Aethlon Hemopurifier in combination with standard of care therapy, Keytruda, is being investigated in a clinical trial of patients with head and neck cancer. The National Institute for Dental and Craniofacial Research (NIDCR) provided AEMD a grant in August 2020 for head and neck cancer research, which will be a joint effort between Aethlon and the University of Pittsburgh’s UPMC Hillman Cancer Center. For multi-institution research, the award is worth up to $3.5 million over five years.

Financial result depicts,

The revenue history of Keytruda further demonstrates the potential of a promising pharmaceutical drug, as well as the fact that the Hemopurifier could help other cancers that are exosome-based. Merck’s most popular medication, Keytruda, delivered $11.1 billion in sales in 2019, up 55 percent from $7.2 billion in 2018. Analysts forecast that by 2025, it would have produced over $22 billion in sales, making it the best-selling drug of all time.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

With the FDA having accepted a supplement to AEMD’s IDE for the Hemopurifier in viral disease to allow testing of the product in patients with SARS-CoV-2/COVID-19 in a recent feasibility trial, COVID-19 could represent yet another opportunity and road to approval for the Hemopurifier.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam